Copaxone 20 mg/ml Solution for Injection, Pre-filled syringe
PDF Leaflet Revision Date: 20 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of high-risk patients for developing clinically definite multiple sclerosis and reducing relapses in relapsing-remitting MS.
Dosage (summary)
20 mg subcutaneously once daily.
Special Populations
- Renal impairment
- Elderly
- Paediatric population
Pregnancy & Breastfeeding
Use during pregnancy only if benefits outweigh risks; unknown if excreted in breast milk.
Key Drug Interactions
- Corticosteroids
- Phenytoin
- Carbamazepine
Contraindications
- Hypersensitivity to glatiramer acetate or excipients
Common side effects
- Injection site reactions
- Flushing
- Chest pain
- Dyspnoea
- Palpitations
Counselling Points
- Rotate injection sites
- Administer at the same time daily
- Seek medical advice for severe reactions
Serious warnings
- Severe hypersensitivity reactions
- Monitor renal function in renal impairment
- Risk of liver injury
Important Disclaimer
The Copaxone 20 mg/ml Solution for Injection, Pre-filled syringe professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
